Early Onset and Familial Gastric Cancer Registry

CompletedOBSERVATIONAL
Enrollment

971

Participants

Timeline

Start Date

December 13, 2005

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Gastric Cancer
Interventions
BEHAVIORAL

questionnaires

Participation in the registry will consist of adequately completing the family history questionnaire (one per family) the gastric cancer risk factor questionnaire and providing a blood sample for future correlative studies. Registry participants (both Patient/Relative and Control cohorts) will be required to submit tissue (both normal and/or tumor) to create a Tissue and DNA repository. Select participants will be invited to undergo Genetic Counseling, eg. those participants who meet clinical criteria for HDGC.

Trial Locations (10)

10065

Memorial Sloan Kettering Cancer Center, New York

Weill Cornell Medical Center, New York

10604

Memorial Sloan Kettering Westchester, East White Plains

11432

Queens Cancer Center of Queens Hospital, Jamaica

11570

Memorial Sloan Kettering Cancer Center at Mercy Medical Center, Rockville Centre

11725

Memorial Sloan Kettering Cancer Center at Commack, Commack

90033

University of Southern California - Norris Cancer Hospital, Los Angeles

07920

Memorial Sloan Kettering Cancer Center at Basking Ridge, Basking Ridge

07748

Memorial Sloan Kettering Monmouth, Middletown

Unknown

Obafemi Awolowo University Teaching Hospital, Ile-Ife

All Listed Sponsors
collaborator

Weill Medical College of Cornell University

OTHER

collaborator

Queens Health Network

OTHER

collaborator

University of Southern California

OTHER

collaborator

Shaare Zedek Medical Center

OTHER

collaborator

Obafemi Awolowo University Teaching Hospital

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00582257 - Early Onset and Familial Gastric Cancer Registry | Biotech Hunter | Biotech Hunter